Optimization of Cardiac Resynchronization Therapy and Its Effects in Patients With Type 2 Diabetes Mellitus: Automatic Optimization vs. Echocardiographic Guided Optimization.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- University of Campania "Luigi Vanvitelli"
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- CRTd responders rate
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Suboptimal optimization of atrio-ventricular (AV) and inter-ventricular (VV) timings could affect the clinical response of CRTd in T2DM patients. Thus, authors hypothesize that automatic sensor guided CRTd optimization could ameliorate clinical outcomes in patients with T2DM. However, authors will evaluate the effects of cardiac resynchronization therapy (CRTd) in patients with type 2 diabetes mellitus (T2DM) optimized via automatic vs. echocardiographic guided approach.Authors will conduct a prospective, multicenter study to recruit, from October 2016 to June 2019, patients with T2DM and heart failure (HF) candidate to receive a CRTd. After CRTd the patients will be optimized via automatic vs. echocardiographic guided approach.
Investigators
Celestino Sardu
researcher
University of Campania "Luigi Vanvitelli"
Eligibility Criteria
Inclusion Criteria
- •heart failure with reduced cardiac pump, NYHA class II/III, indication to receive a CRTd.
Exclusion Criteria
- •NYHA class IV, previous CRTD implantation, neoplastic disease, inflammatory chronic disease.
Outcomes
Primary Outcomes
CRTd responders rate
Time Frame: 12 months
The authors will evaluate the CRTd responders rate in terms of patients that will experience the reduction of NYHA class, improvement of HF symptoms, and improvement of left ventricle ejection fraction.